Starting 2023 with Better Health

In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie provides several tips to starting off the new year with better health. He recommends three new books: one about living to a hundred through the Blue Zone diet, another about the new science of breathing properly, and a third one on de-stressing by enjoying the company of birds in your backyard. Dr. Durie advises to keep your mind away from the troubles of the day and to focus on improving your overall health in 2023.

IMF Fuels Its Digital Strategy with the Power of Cloud Technology from Amazon Web Services and Salesforce

Imagine being served up content that meets you where you are in your patient journey. You visit the IMF website and learn what clinical trials you qualify for, or which myeloma experts can best help you in your region. To better serve its patient community, the International Myeloma Foundation (IMF) has deployed Data Lakes for Nonprofits – powered by Amazon Web Services (AWS) and offered by AWS and Salesforce. The goal is to create a more patient-focused digital ecosystem that meets patients, donors, and other IMF community members where they are. Learn about this exciting new partnership now.

Register Now for the February 15th Virtual Regional Community Workshop 

The IMF will host a Virtual Regional Community Workshop for the Midwest region on Wednesday, February 15, 2023, at 5:30 p.m. CST / 6:30 p.m. EST. Jonathan Kaufman, MD (Winship Cancer Institute, Emory University— Atlanta) will review multiple myeloma basics, common symptoms and side effects, advances in how myeloma is initially diagnosed, stages of myeloma treatment, induction therapy, and transplant. Rafat Abonour, MD (Indiana University – Indianapolis) will talk about types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, and clinical trials. IMF Nurse Leadership Board member Daniel Verina, DNP, ACNP-BC (Mount Sinai Medical Center Hematology – New York) will discuss how patients can manage the side effects of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions. 

Take Action by Being Part of a Global Myeloma Mash-Up Video. Submit Your Video Now!

The IMF wants YOU to raise myeloma awareness on a global scale by sharing your #MYelomaSTORY. When you share your story, you raise awareness of myeloma; create a stronger and more connected community; help doctors, researchers, and other healthcare professionals understand the importance of their work; and accelerate the pathway to a cure. 

Participating is simple: 

• Take a video of yourself answering the question: "In ONE WORD, my myeloma story is...” 
• Upload your video using the submission form linked below.  

Register Now for the In-Person Patient and Family Seminar in Boca Raton, FL

Back in person for the first time since 2019, the International Myeloma Foundation (IMF) is excited to announce that the 2023 Boca Raton Patient and Family Seminar is taking place on March 17-18, 2023, in Boca Raton, Florida. In the coming days, the IMF will announce our expert speaker lineup for the upcoming Boca Raton Patient and Family Seminar. We promise you will not want to miss this unique opportunity to hear from top myeloma experts from around the world. In-person seating is limited; register today before attendance is full.

15th Annual Miles for Myeloma Back In Person and Virtual

The Miles for Myeloma Hybrid 5K Run/Walk will be on April 29, 2023, in FDR Park in Philadelphia. Participants can take part in person or virtually. You can also make a difference with the purchase of a Tribute Path Plaque. Learn more about these tribute plaques as well as how to register.

The Third Part in a Series of Videos on Bispecific Antibodies 

In this video, IMF Chief Medical Officer Dr. Joseph Mikhael discusses the main benefits of bispecific antibody therapies, such as the ability to administer these drugs off the shelf, their mechanisms of action, how they can recognize antigens on the surface of multiple myeloma, and more. He also points out the potential side effects of bispecific therapies.

#ASKDRDURIE | Dr. Durie's Weekly Web Video Series

Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma?